About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
SEC Filings
Filing date | Form | Description | Filing Group | View |
---|---|---|---|---|
4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
SC 13G/A | An amendment to the SC 13G filing |
3,4,5
|
View HTML | |
SC 13G/A | An amendment to the SC 13G filing |
3,4,5
|
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
3,4,5
|
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
3,4,5
|
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
3,4,5
|
View HTML | |
8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
8-K | Report of unscheduled material events or corporate event |
Current Reports
|
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
Current Reports
|
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML |
Copyright Morningstar
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Ronald Aldridge
Constellation Pharmaceuticals
+1-617-714-0539
ron.aldridge@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com